Table of Contents
ISRN Minimally Invasive Surgery
Volume 2012, Article ID 763290, 7 pages
http://dx.doi.org/10.5402/2012/763290
Clinical Study

Laparoscopic Risk-Reducing Salpingo-Oophorectomy: The Brigham and Women's Experience

1Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
2Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

Received 3 March 2012; Accepted 24 March 2012

Academic Editors: F. P. Secin and A. Tinelli

Copyright © 2012 Melina Shoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Julian-Reynier, J. Mancini, E. Mouret-Fourme et al., “Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations,” European Journal of Human Genetics, vol. 19, no. 5, pp. 500–506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Clark and S. M. Domchek, “Clinical management of hereditary breast cancer syndromes,” Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 1, pp. 17–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. R. Rebbeck, N. D. Kauff, and S. M. Domchek, “Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers,” Journal of the National Cancer Institute, vol. 101, no. 2, pp. 80–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Domchek, T. M. Friebel, C. F. Singer et al., “Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality,” Journal of the American Medical Association, vol. 304, no. 9, pp. 967–975, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Domchek, T. M. Friebel, S. L. Neuhausen et al., “Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study,” The Lancet Oncology, vol. 7, no. 3, pp. 223–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Eisen, J. Lubinski, J. Klijn et al., “Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study,” Journal of Clinical Oncology, vol. 23, no. 30, pp. 7491–7496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. N. Westin, C. C. Sun, K. H. Lu et al., “Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma,” Cancer, vol. 117, no. 12, pp. 2659–2667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Miller, P. Roussi, M. B. Daly, and J. Scarpato, “New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy,” Clinical Cancer Research, vol. 16, no. 21, pp. 5094–5106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. A. Rocca, B. R. Grossardt, M. de Andrade, G. D. Malkasian, and L. J. Melton, “Survival patterns after oophorectomy in premenopausal women: a population-based cohort study,” The Lancet Oncology, vol. 7, no. 10, pp. 821–828, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. N. D. Kauff, J. M. Satagopan, M. E. Robson et al., “Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1609–1615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. M. Meeuwissen, C. Seynaeve, C. T. M. Brekelmans, H. J. Meijers-Heijboer, J. G. M. Klijn, and C. W. Burger, “Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer,” Gynecologic Oncology, vol. 97, no. 2, pp. 476–482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. A. Kenkhuis, G. H. de Bock, P. Oude Elferink et al., “Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers,” Maturitas, vol. 66, no. 3, pp. 310–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Manchanda, A. Abdelraheim, M. Johnson et al., “Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status,” International Journal of Obstetrics and Gynaecology, vol. 118, no. 7, pp. 814–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. F. Escobar, D. C. Starks, A. N. Fader, M. Barber, and L. Rojas-Espalliat, “Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: Surgical outcomes and learning curve analysis,” Gynecologic Oncology, vol. 119, no. 1, pp. 43–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. C. Powell, E. Kenley, L. M. Chen et al., “Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy,” Journal of Clinical Oncology, vol. 23, no. 1, pp. 127–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Dindo, N. Demartines, and P. A. Clavien, “Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Annals of Surgery, vol. 240, no. 2, pp. 205–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. R. Rebbeck, H. T. Lynch, S. L. Neuhausen et al., “Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1616–1622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Callahan, C. P. Crum, F. Medeiros et al., “Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3985–3990, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Sidon, S. Ingham, T. Clancy et al., “Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women,” British Journal of Cancer, vol. 106, no. 4, pp. 775–779, 2012. View at Publisher · View at Google Scholar